Doxazosin News and Research

RSS
Doxazosin mesylate, a quinazoline compound, is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.
Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

Gentle combination of FDA-approved drugs could combat photoreceptor degeneration in mice

Statins could be effective against metastatic small cell lung cancer

Statins could be effective against metastatic small cell lung cancer

Inappropriate prescriptions for the elderly prevalent in primary care

Inappropriate prescriptions for the elderly prevalent in primary care

Diuretic drug works best at reducing risk of heart failure in hypertension

Diuretic drug works best at reducing risk of heart failure in hypertension

Diuretic reduces risk for type of heart failure that affects women more often than

Diuretic reduces risk for type of heart failure that affects women more often than

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

Evidence strongly supports diuretics as initial metabolic syndrome therapy, especially in black patients

Gene variations associated with effectiveness of blood pressure medications

Gene variations associated with effectiveness of blood pressure medications

Prostate drug doxazosin blocks receptor in heart muscle, increasing risk of heart failure

Prostate drug doxazosin blocks receptor in heart muscle, increasing risk of heart failure

Study to compare prostate surgery and drugs

Study to compare prostate surgery and drugs

FDA Approves PROSCAR® Combined With Doxazosin to Reduce the Risk of Benign Prostatic Hyperplasia Symptoms

FDA Approves PROSCAR® Combined With Doxazosin to Reduce the Risk of Benign Prostatic Hyperplasia Symptoms